camptothecin has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biswas, SC; Greene, LA; Jackson-Lewis, V; Malagelada, C; Ryu, EJ | 1 |
1 other study(ies) available for camptothecin and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Camptothecin; DNA-Binding Proteins; Gene Expression Regulation; Humans; Hydrogen Peroxide; Male; Melanins; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Growth Factor; Neurons; Oxidopamine; Parkinsonian Disorders; PC12 Cells; Phosphorylation; Protein Kinases; Protein Processing, Post-Translational; Rats; Repressor Proteins; Ribosomal Protein S6 Kinases, 70-kDa; RNA; RNA Interference; Rotenone; Signal Transduction; Substantia Nigra; TOR Serine-Threonine Kinases; Transcription Factors; Transcription, Genetic; Transfection; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Tunicamycin | 2006 |